Results of the State Diabetes Mellitus Register in Bukhara, Navoi, Khorezm Regions and the Republic of Karakalpakstan
Introduction. Diabetes mellitus (DM) is an important medical and social problem. The objective of the study — to analyze the adequacy of the diagnosis and treatment of patients based on the results of the register in the four regions of the Republic of Uzbekistan. Materials and Methods. Among 14 214 patients with DM from Bukhara, Navoi, Khorezm regions and the Republic of Karakalpakstan, the analysis of card-registers has been performed. Results. Analysis of the register data in the four regions of Uzbekistan showed a lack of work on the diagnosis, treatment and prevention of diabetes complications. There is a lack of diagnosis and registration of complications of diabetic nephropathy and diabetic retinopathy in Bukhara, Khorezm regions, the Republic of Karakalpakstan, the lack of diagnosis and detection of macroangiopathy in Bukhara, Navoi, Khorezm regions, the Republic of Karakalpakstan. There is almost no achievement of target levels of glycemia in all regions, the regimen of intensive insulin therapy, as well as biguanide drugs, are administered not enough among patients with type 2 DM in all regions, which leads to an increased risk of diabetes complications. Physicians are not aware of macrovascular diabetic complications and the treatment of hypertension, angiotensin converting enzyme inhibitors (especially in the Khorezm region and the Republic of Karakalpakstan) contributing to the prevention of diabetes complications, and in particular diabetic nephropathy, are underprescribed. Conclusions. Analysis of the register data in the four regions of Uzbekistan showed a lack of work on the diagnosis, treatment and prevention of DM complications.
Ismailov SI, Berdykulova DM. Pozdnie oslozhnenija saharnogo diabeta u lic, prozhivajushhih v respubliki Uzbekistan. [Late complications of diabetes mellitus in individuals residing in Republic of Uzbekistan]. International Journal of Endocrinology. 2012; 8 (48). Russian.
DREAM (Deabetes Reduction Assessment with ramipril and rosiglitasone Medication) Trial Investigators. Effect of rosiglitasone on the frequency of diabetes in patients with impaired glucose tolerance or im-paired fasting glucose: a randomized controlled trial. Lancet 2006; 368:1096-1105.
Al-Maskari F, El-Sadig M, Norman J N. The prevalence of macrovascular complications among diabetic patients in the United Arab Emirates. Cardiovascular Diabetology. 2007 6: 24.
Litwak L, Goh SY, Hussein Z. et al. Prevalence of diabetes complications in people with type 2 diabetes mellitus and its association with baseline characteristics in the multinational A1chieve study. Diabetology Metabolic Syndrome. 2013; 5:57.
Nosadini R, Tonolo GJ. Cardiovascular and renal protection in type 2 diabetes mellitus: the role of calcium channel blockers. Am SocNephrol. 2002 Nov; 13 Suppl 3:S216-23.
UKPDS 80. N.EngJMed 2008; 359.
World Health Organization. Definition and Diagnosis of Diabetes Mellitus and Intermediate Hyperglyce¬mia. Report of WHO/IDF Consultation. 1-46.2006. http://www.who.int.
Yau JW, Rogers SL, Kawasaki R. Global prevalence and major risk factors of diabetic retinopathy. Diabetes Care. 2012 Mar; 35 (3):556-64. doi: 10.2337/dc11-1909.
This work is licensed under a Creative Commons Attribution 4.0 International License.
© "Publishing House "Zaslavsky", 1997-2019